• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

Sustaining Gains, Expanding Horizons – Side event marking the 20th anniversary of South Asia’s Kala-azar Elimination Initiative

14 October 2025

Columbo, Sri Lanka

From A 20-Year Journey of Regional Kala-azar Elimination Commitment and Innovation Toward a Healthier South-East Asia through Multi-Disease Elimination Building on the legacy of kala-azar elimination for integrated public health delivery

Kala-azar, or visceral leishmaniasis, has long been one of the most devastating neglected tropical diseases in South Asia, with Bangladesh, India, and Nepal carrying nearly 70% of the global disease burden two decades ago.

In 2005, high-level political commitment from these countries led to the launch of the Regional Kala-azar Elimination Initiative. Guided by WHO and supported by donors, research institutions, and development partners, the initiative drove advances in treatment, diagnostics, and vector control, while strengthening cross-border collaboration. As a result, kala-azar cases have fallen by 95% in the last decade, and 98% of endemic areas have reached elimination targets – a historic milestone in global neglected tropical disease control.

This side event marks the 20th anniversary of the Regional Kala-azar Elimination Initiative and provides an opportunity to reflect on two decades of progress. The discussions will focus on key learnings, emerging challenges, opportunities for continued collaboration, and how to adapt the learnings for multi disease elimination in the region.

DNDi is co-hosting the side event in collaboration with the Government of India, Government of Nepal, WHO SEARO and Gates Foundation.

Agenda

Opening remarks and introduction

Time: 17:00

Keynote address

Time: 17:16

Journey towards the India sub-continent free from kala-azar – the power of regional partnership, lessons learnt and the way forward
Nirmal Kumar Ganguly

Panel discussion: Success factors, lessons learnt and the way forward to accelerate and sustain elimination of kala-azar in South-East Asia

Time: 17:23

Speakers:

  • Country representatives (India, Bangladesh, Nepal)
  • Representative from DNDi
  • Representative from MSF

Keynote address

Time: 17:43

Regional Multi-Disease Elimination (MDE) Initiative – Opportunities, challenges and the way forward
Suman Rijal, Director, Communicable Diseases, WHO-SEARO

Panel discussion: Accelerating and sustaining elimination of kala-azar through multi-disease elimination approach in South-East Asia

Time: 17:51

Speakers:

  • Country representatives (Bhutan, Sri Lanka, Thailand)
  • Representative from Gates Foundation
  • Representative from PATH

Concluding remarks

Time: 18:26

livestream link (Password: RC78@side)
Registration & access Sustainable Development Partnership Visceral leishmaniasis Asia

Other events

Loading...
2-5 November 2025

João Pessoa, Brazil

MedTrop 2025

12-14 October 2025

Berlin, Germany & Online

World Health Summit 2025

30 September - 3 October

Bad Hofgastein, Austria and online

European Health Forum Gastein 2025

30 September - 2 October 2025

Kampala, Uganda

NNN Conference 2025

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License